People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LyGenesis Inc. | — | Biotechnology | Series B | $25.8M | $173.9M | 2018 |
| e-Nicotine Technology, Inc. | — | Biotechnology | Seed | $7.0M | $17.8M | 2013 |
Michael Hufford at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Hufford on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Williams | 1 | 10 |
| James Mellon | 1 | 10 |
| Gregory Bailey | 1 | 8 |
| Richard Brenner | 1 | 6 |
| Don B Watkins | 1 | 1 |
| Martin Wensley | 1 | 1 |
| Fraser B Bullock | 1 | 1 |
| Eric Legasse | 1 | 1 |
| Paulo Fontes | 1 | 1 |
| Steve Felstead | 1 | 1 |
| Eric Lagasse | 1 | 1 |
| Christopher B Munday | 1 | 1 |
| Justin Briggs | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.